Skip to content

Evaluation of the Efficacy of Washed Fecal Microbiota Transplantation in Treating Refractory Slow-Transit Constipation in the Elderly and Mechanistic Insights Based on Multi-Omics Approaches

Evaluation of the Efficacy of Washed Fecal Microbiota Transplantation in Treating Refractory Slow-Transit Constipation in the Elderly and Mechanistic Insights Based on Multi-Omics Approaches

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115480
Enrollment
Unknown
Registered
2025-12-26
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Slow transit constipation

Interventions

Trial group (conventional treatment combined with WMT):Washed micribiota transplantation
Control group (conventional treatment group):Conventional treatment of constipation

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Functional constipation was diagnosed according to the Rome IV diagnostic criteria, and slow colonic transit (>48h) was confirmed by colonic transit test , which was ineffective after at least 4 weeks of comprehensive treatment with laxative drugs, promoting intestinal motility and adjusting diet routine; 2.Age>=60 years old, regardless of gender; 3.No contraindications to WMT were found; 4.Understand the whole process of the study, voluntarily participate in and sign the letter of intent;

Exclusion criteria

Exclusion criteria: 1.Severe organic diseases of digestive tract, such as tumor, inflammatory bowel disease, ulcer, etc; 2.Severe heart, liver, kidney and other important organ dysfunction; 3.Patients who have used antibiotics, probiotics and laxatives (outside the experimental regulations) in recent 1 month; 4.Patients with mental illness who cannot cooperate with treatment; 5.Patients with irritable bowel syndrome; 6.A history of abdominal surgery.

Design outcomes

Primary

MeasureTime frame
Frequency of defecation per week;

Secondary

MeasureTime frame
Constipation symptoms;Stool characteristics;Quality Of Life;Colonic transit time;Adverse event;

Countries

China

Contacts

Public ContactLi Qianlong

Suining Central Hospital

120731660@qq.com+86 825 2267610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026